Data / Form D filings / Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc.: Form D filings
Inhibikase Therapeutics, Inc., a pharmaceuticals company in Atlanta, GA, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on June 4, 2024, reports an offering of $8 million with nothing sold yet to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3350 RIVERWOOD PARKWAY SE, SUITE 1900, Atlanta, GA, 30339
- Phone
- (678) 392-3419
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1750149
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | New notice | $7,999,999 | $0 | $7,999,999 | 1 | May 20, 2024 | sec.gov |
| Feb 7, 2023 | New notice | $4,200,000 | $4,200,000 | 1 | Jan 27, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul H. Grint | Director | |
| Milton H. Werner | Executive Officer, Director | |
| Gisele H. Dion | Director | |
| Roy H. Freeman | Director | |
| Garth H. Lees-Rolfe | Executive Officer | |
| Dennis H. Berman | Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of Jun 3, 2024 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Inhibikase Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.